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A Perspective on Nonmutagenic Mechanisms
in Carcinogenesis
by Raymond W. Tennant
Although there iscompellingevidence formultiplemutageniceventsinthe induction ofcancers,there isalso
substantial evidence in support of nonmutagenic mechanisms. It is proposed that the genetic basis of
noninduced or spontaneous tumors, as well as cancers induced by nonmutagens, involves heritable changes in
the regulation of gene expression.
Introduction
Cancer is a disease ofenvironment and genetics. There
is a strong scientific consensus, codified by the Interna-
tional Agency for Research on Cancer [IARC (1)], that
environmental factors such as smoking, exposure to sun-
light, exposure to certain organic chemicals, and other
occupational and environmental factors establish a solid
basis for an environmental component in the induction of
cancers. Data derived from epidemiological studies have
identified differences in the prevalence and types of cer-
tain tumors between geographical areas. Also, differences
in the rate or frequency of the development of specific
cancers in migrant populations provides support for an
environmental component (2,3).
Likewise, there is compelling evidence for a genetic
basis ofhuman cancer. Thisincludes evidenceforheritable
susceptibilities between populations ofhumans, for exam-
ple, skin cancer among fair skinned Anglo-Saxons and
evidence for genetic mechanisms in induced carcinogene-
sis. The role ofgenetic mechanisms in carcinogenesis was
first proposed by Theodore Boveri in 1924 (4), who articu-
lated the earliest version ofthe somatic mutation hypoth-
esis. Subsequently, otherevidencefortheroleofmutagenic
changes in carcinogenesis have come from a variety of
sources. These lines of evidence include the chromosomal
alterations that have been identifled in many rodent and
human tumors. In fact, most human and rodent tumors
that have been examined show generalized chromosomal
damage as well as specific chromosomal mutations or
translocations (5). Also, overthepastdecade, evidence has
emerged associating up to a hundred different dominant
genes (i.e., oncogenes) with carcinogenesis. The role of
mutations in the activation of these genes has provided a
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genetic basis for both initiating and promoting events in
tumor development (6). Subsequently, evidence has
emerged for anti-oncogenes or tumor-suppressor genes,
which have an importantregulatoryrole in controlling the
expression or function of oncogenes (7). The function of
these suppressor genes can be lost through mutation or
translocation. Subsequent observations have provided a
schemeinwhichmultiplegenetic changes canbeidentified
and associated with sequential alterations giving rise to
tumors in humans (8).
These observations represent a very brief and only a
partial list ofthe data that are available to support a role
for specific genes in carcinogenesis and for specific altera-
tions or mutations in those genes that initiate or promote
the carcinogenic process. In the face of such compelling
data,itisdifficulttoconsiderthepossibilitythattheremay
be alternative mechanisms ofcarcinogenesis.
Evidence Supporting Nonmutagenic
Mechanisms
One of the strongest lines of evidence in support of
nonmutagenic mechanisms are the chemicals that demon-
strate no consistent mutagenic properties, yet have the
capacity to induce tumors in rodent bioassays (9). Our
operational definition of a nonmutagen is a chemical or
substancethatdoes notdemonstrate evidenceofone ofthe
structural alerts associated with electrophilic potential
and that the chemical does not induce mutations in the
Salmonella assay nor induce chromosomal effects when
measured in vivo (eitherinduction ofchromosome aberra-
tions ormicronuclei). Although othermechanisms ofgeno-
toxicity or mutagenesis exist, for example, interference
with chromosomal metabolism or the mechanics of chro-
mosome segregation, there have been no assays identified
yet that are capable ofresolving those specific properties
that appear to be associated with carcinogenesis. TheR. W TENNANT
operational definition that we use, therefore, may miss
some proportion of incipient or indirect mutagens, but it
provides the highest degree of specificity for carcinogen
identification. We believe that this operational definition
definesthechemicalgroupswiththehighestprobabilityof
direct interaction with and damage to DNA. Chemicals
that lack these properties comprise a very structurally
diverse group (Table 1).
Iable 1. Nonmutagenic carcinogens.a
Chemical
Aldrin
Allyl isovalerate
11-Aminoundecanoic acid
Benzaldehyde
Benzene
Benzofuran
Benzyl acetate
Butyl benzyl phthalate
C.I. Vat yellow 4
Chlordane (technical grade)
Chlorendic acid
Chlorinated paraffins: C12, 60% chlorine
Chlorinated paraffins: C23, 43% chlorine
Chlorobenzilate
Chlorothalonil
Cinnamyl anthranilate
Decabromodiphenyl oxide
Di(2-ethylhexyl) adipate
Di(2-ethylhexyl) phthalate
1,4-Dichlorobenzene (p-dichlorobenzene)
p,'-Dichlorodiphenyldichloroethylene
Dicofol
N,N'-Diethylthiourea
1,4-Dioxane
Furfural
Furosemide
Heptachlor
Hexachloroethane
Hydroquinone
Isophorone
d-Limonene
Malonaldehyde, sodium salt
Melamine
Mereaptobenzothiazole
a-Methylbenzyl alcohol
Monuron
Nalidixic acid
Nitrilotriacetic acid (NTA)
N-Nitrosodiphenylamine
Pentachloroethane
Pentachlorophenol
Phenylbutazone
Piperonyl sulfoxide
Polybrominated biphenyl mixture (Firemaster FF-1)
Reserpine
2,3,7,8-Tetrachlorodibenzo-p-dioxin
1,1,1,2,-Tetrachloroethane
1,1,2,2-Tetrachloroethane
Tetrachloroethylene
1,1,2-Trichloroethane
Trichloroethylene (without epichlorohydrin)
2,4,6-Trichlorophenol
Trimethylthiourea
Tris(2-ethylhexyl)phosphate
Zearalenone
aAll chemicals listed are negative for structural alerts and were
negative in Salmonella.
Genetic Basis for Spontaneous
Tumors
Another line ofevidence that supports a nonmutagenic
originofsome cancers canbe derived fromthe occurrence
of spontaneous tumors. Virtually all mammalian species
have demonstrated evidence of tumors when older indi-
vidualshavebeenexamined.Thebestdataontheincidence
and patterns of spontaneous tumors are derived from
studies with inbred mouse and rat strains. Among the
most complete data available are those derived from the 2
year rodent bioassays conducted by the National Toxicol-
ogyProgram [NTP (10,11)]. In the protocol used to assess
carcinogenicity in rodents, there are concurrent controls
of50 mice or rats ofeach sex that are held for a 104-week
exposure period and subsequently undergo complete
postmortem evaluation. The thousands of animals that
have been studied have demonstrated fairly consistent
patterns of spontaneous tumor development, which has
been maintained over many generations. Both mice (i.e.,
B6C3F1 hybrid) and rats (i.e., F344 strain) are housed
under highly controlled conditions, and the diets they are
fed are well characterized and contain known, but
extremely negligible, amounts ofpotentially carcinogenic
substances. The highly defined and controlled environ-
mentprovidesfew,ifany, sourcesofcarcinogens.Thus,the
constancyofthepatternoftumordevelopmentwithineach
sex and species indicates that there are particular genetic
determinants that are responsible for the occurrence of
spontaneous tumors.
The actual frequency of tumors developed at certain
sitesdofluctuate and overtime; forexample, theincidence
of mammary tumors or leukemia in rats has tended to
increase. The increase in these latter tumors has been
associated with improvement in maintenance conditions,
thatis,areductioninendogenousvirusesandbacteriathat
could decrease the health of the animals and also
attributed to improved dietary conditions that result in
relatively high weight gain (11). Thus, there are environ-
mental factors that can influence the incidence of spon-
taneous tumors but do not significantly influence the
pattern with which these tumors develop. The origin of
spontaneous tumorsisunclear.Aspecificgeneticinfluence
hasidentifiedthehighfrequencyoflivertumorsoccurring
inB6C3F1 micethatisattributedto alocuscalledHcs(12).
The genetic basis of other types of spontaneous tumors
has not been well studied, but crosses between strains
showing high tissue-specific tumor incidence and other
strains showing low tumor incidence at the same site,
generally results in an intermediate level of tumor
expression in the F1 progeny, suggesting that in most
casestheexpressionofspontaneous tumorsisdominantor
semidominant (13).
Among various ideas proposed to account for spon-
taneous tumorigenesis is the concept of DNA damage of
endogenous origin. That is, mutations that could occur
either as a consequence of mistakes in DNA repair and
replicationmechanisms (14)orfromdamagethatoccursas
a consequence of normal metabolism through which
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variousradicalsofoxygen, suchassuperoxide orhydroxyl,
are generated (15-17). However, it is difficult to reconcile
these hypotheses with the spontaneous tumor patterns
that develop in the B6C3F1 mice and F344 rats because
neither can account for the tissue specificity of spon-
taneous tumor incidence. If generalized DNA replication
or repair errors or oxidative damage were responsible for
the spontaneous tumors, one would expect a more gener-
alized pattern of spontaneous tumor development that
wouldberelatedtoeither'thetissueswiththehighestlevel
ofendogenous cellularproliferationortothosetissuesthat
have the highest levels of endogenous oxidative metabo-
lism. The pattern oftumors observed do not reflect these
patterns (10), andothermechanismsbywhichsuchtumors
could arise should be considered.
It also has been proposed that tissues in which spon-
taneous tumors arise undergo a higher level of spon-
taneous initiation and that the action of nonmutagenic
carcinogens may involve only the promotion or clonal
expansionofsuchspontaneouslyinitiatedcells.Toevaluate
this hypothesis, we have looked at the sites of tumori-
genesis that have been associated with exposure to 154
chemicals identified as carcinogens in the NTP bioassays
(9). As shown in Figure 1, the carcinogens have induced
tumors in about 30 tissue sites, butthe majority ofchemi-
cals canbefound to be active atapproximately10different
sites. These frequencies of induced tumorigenesis were
then compared to the sites of spontaneous tumorigenesis
demonstrated in control animals. One example, male
Fischer rats (Fig. 2), shows a high level of spontaneous
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tumorigenesis in the hematopoietic system,whichis a site
ofrelatively high cell proliferation. However, the hemato-
poietic system is comparable to the adrenal gland in both
spontaneous and induced tumor incidence, but the level of
endogenous cellular proliferation is significantly lower in
adrenal tissue. Another site ofrelatively high endogenous
cellproliferation isthe skin,which shows significantlyless
spontaneous tumorigenesis and was not a site of tumors
inducedbynonmutagenic carcinogens. Sitesofthehighest
levels ofinduced tumors were the liver and kidney, which
differ considerably in both levels ofendogenous oxidative
metabolism and spontaneous tumor incidence.
Theseresults,therefore, suggestthefollowing:a)notall
sites in the body are equally at risk for chemical-induced
tumorigenesis, b) the sites of induced tumors are not
directly related to the level of endogenous cellular pro-
liferation, c)the spontaneouspatterns oftumorigenesis do
not appear to dramatically influence the sites of tumor
induction by exogenous chemicals and, d) the genetic
influence on spontaneous tumors appears to be the pre-
dominant factor in their expression. Ifindirect mutations
of oncogenes are involved in the development of spon-
taneous tumors, the source of those spontaneous muta-
tions is also unclear, and relatively little information is
available. The only extensive studies that have been con-
ducted involve the liver in the B6C3F1 mouse. Spontaneous
mutations involving the 12th or 13th codon of the v-H-ras
gene have been identified in many spontaneous and induced
tumors (12), but mutated or translocated forms of other
oncogenes have not been studied asetensively.
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FIGURE 1. Occurrence oftumor sites inducedby154 carcinogens testedbythe NTP accordingto sex and species. SeeAshbyandTennant (9) forkey to
sites.
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FIGLURE 2. The frequencies ofinduced tumorigenesis by nonmutagenic carcinogens compared to the spontaneous rates for control animals.
Mechanisms of Nonmutagenic
Carcinogenesis
The theories proposed to account for the carcinogeni-
city ofnonmutagenic chemicals can be combined into two
major groups: indirect mutagenesis and altered gene
expression. They are not mutually exclusive mechanisms.
It is very possible that some chemicals involve a combina-
tion of the two mechanisms, and there are even data to
suggest that among the mutagenic carcinogens, indirect
mutagenesis or alterations in the expression ofimportant
target genes can be critical components in the carcino-
genic processes (19).
Indirect Mutagenesis
Currently, the most intense speculation about nonmuta-
genic carcinogens concerns the relationship between tox-
icity, sustained tissue damage, and induced cellular
proliferation or mitogenesis (20). Cell proliferation gener-
allyrefers to compensatory or reparative cell division that
is a consequence of toxicity, whereas mitogenesis gener-
ally refers to the capacity of a chemical or substance to
directly elicit cell division. Investigations by Totter (15),
Ceruti (16), and Ames and Gold (17) have proposed thatby-
products ofthe normal oxidative metabolism ofcells gives
rise to relatively high levels of free radicals such as
superoxide or hydroxyl that have the capacity to damage
DNA and to induce mutations. Ames and Gold (17) have
focused on chemicals thatinduce toxicity and suggestthat
reparative processes associated with toxic injury such as
the infiltration of macrophages can increase the level of
oxyradicals. They propose that toxic injury sustains cell
proliferation and can promote the development of tumors
by providing for the clonal expansion ofcells damaged by
oxyradicals. Evidence in support of this mechanism has
been offered by the identification of8-hydroxyguanosine.
This is an altered DNA base that occurs as a result of
oxyradical-induced DNA damage. However, there is no
way to determine whether such altered bases occur in
healthy cells that are dividing and have the capacity to
repair such damage orwhetherthey occur predominantly
in cells that are irreversibly injured by toxicity and thus
could not contribute to either the proliferative process or
to subsequent development of tumors.
A second mechanism by which endogenous sources of
DNA damage could arise has been summarized by Loeb
(14). He has proposed that lesions induced in DNA by
mistakes in replication and repair processes induce spon-
taneous mutations and that such mutational events could
account for a significant proportion ofendogenously initi-
ated cells.
The major argument against the amplification or clonal
expansion of endogenous DNA damaged cells or mutated
cells (the "mitogenesis and mutagenesis" theory) come
from two lines of evidence. The first is derived from an
extensive evaluation of a number of chemicals that induce
organ-specific toxicity in the 2-year rodent bioassays.
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Toxicitythat is sustained formuch ofthe 104-week period
of chemical exposure in these bioassays can result in
proliferative responses such asinduction ofhyperplasia in
specific tissues. Such changes can occur in the absence of
neoplasia (19). The bioassays are carried out for 2 years,
whichrepresents approximately 60%ofthelife spanofthe
animal. The animalsundergo completepostmortemexam-
ination atthe end ofthebioassayperiod, and there is little
basis for arguing that tumors might be detected if the
injury was sustained longer or if the animals were
observed longer.
The second line of evidence is based on the pattern of
spontaneous tumors that occurs inthe mice and rats used
in the bioassay. As discussed previously, the data do not
support generalized induction of spontaneously initiated
cells either by errors in proliferation and repair or by
oxidative damage. Comparisons of the sites of spontane-
ous tumors with the sites ofhighest levels ofendogenous
cellular proliferation or ofoxidative metabolism showvery
little relationship to the pattern of spontaneous tumors.
Therefore, it appears unlikely that the spontaneously
occurring tumors in rodents canbe directly accounted for
by indirect mutagenesis mechanisms. These data do sup-
port the concept that the spontaneous tumors arise as a
result ofspecific genetic determinants in the animal. This
does not exclude the possibility that some chemicals may
havethecapacitytoinduceindirectoxidative damage orto
increase the level ofcellular and repair proliferation mis-
takes, andtosubsequentlyclonallyamplifythesemistakes
whentheyoccurin an oncogene orsuppressorgene. Itis a
plausible mechanism for some tumorigenesis, but it is
unlikely to account for the full range of carcinogenic
effects observedamongthelargenumberofnonmutagenic
carcinogens.
Altered Gene Expression
If the clonal amplification of spontaneous or indirectly
initiated cells is not a common mechanism of carcino-
genesis, then how mayproliferative processes give rise to
tumors? There are different lines ofevidence that can be
interpreted to.support arole for alterations in the expres-
sion of one or more of the critical proto-oncogenes or
proto-suppressor genes, that is, the endogenous forms of
theoncogenes orsuppressorgenesplaycriticalrolesinthe
complex regulatory pathways that control normal cell
functions. An analogy canbe drawn fromthe processes of
differentiation wherein sequential changes in the
expression of genes and the responses of differentiating
cells to the gene products result in heritable alterations in
thepattern ofgeneexpression. Suchchanges areacquired
by, and oftenmodifiedin,progenycells.Whenappropriate
stages ofdifferentiation are reached, the pattern ofgene
expression can become fixed and subsequently inherited
by daughter cells arising in those tissues. Therefore, it is
possible that some chemicals orenvironmental agents can
act by altering the expression ofthese critical regulatory
genes and give rise to progeny cells inwhich the heritable
phenotypic change provides a growth advantage. The
development of tumors in response to so-called "solid-
state" carcinogens, such as plastic strips, films, or calculi
couldinvolve such amechanism. The cells adaptto growth
inthepresence of, oronthe foreign objects. Progressively,
more dysregulated cells can emergewith a growth advan-
tage that eventuallybecomes a tumorphenotype (21). The
question of whether mutations are induced in critical
targets in such cells has notbeen addressed. Therefore, it
is inadequate to assume that mutations are required to
elicit neoplastic growth under these conditions.
Hormonal carcinogenesis provides a second line ofevi-
dence. The profound changes on normal regulatory pro-
cesses induced by hormones involve complex interactions
with surface or intracellular receptors and the transduc-
tion of signals to the nucleus where changes in gene
expression are affectedbythe action ofvarious transcrip-
tion factors. Oncogenes that play roles in these processes
have been identified byvirtue ofthe mutated forms ofthe
genes that exist in and were transduced by retroviruses.
However, there are normal cellular counterparts for such
genes. For example, the erbA protein functions as an
intracellular receptor for thyroid hormone (T3) and func-
tions as a negative regulator of transcription (22). The
mutatedformoferbAhasbeendemonstratedtoplayarole
in tumorigenic processes. However, constitutive expres-
sion ofthe endogenous c-erbAproto-oncogene can plausi-
blyresult in similar events. For example, ifa chemical can
function as a ligand forthe thyroid hormone receptor and
significant levels of the chemical are present for pro-
tracted periods of time, it is possible that the normal
regulatoryfunctions ofthe receptorwillbe subverted and
that the erbA gene product would be constitutively pro-
duced.Theconsequencecouldbeadysregulatedpatternof
cellular proliferation because there is selection for more
rapidly proliferating cell populations. Daughter cells also
requiredtoexistinthepresenceofthechemicalwouldalso
possess the altered phenotype. Such dysregulated pro-
liferating cells would provide a fertile environment in
which subsequentgenetic changes could occurandlead to
a malignant phenotype. Thus, the proliferation ofthyroid
cells may be fundamentally different in the presence of a
nonmutagenic chemical that can alter the process ofgene
expression.
Pathways such as that proposed for the erbA oncogene
provide abasis forviewingthe emergenceofsome cancers
as an adaptive process. In this hypothesis it is not the
direct action ofthe chemical thatinduces specific changes
in cells, but rather that the chemical elicits adaptive
responses on the part of cells that lead to deregulated
growth patterns andthe emergence ofneoplasticvariants
(21).Whilethismayseemtobeaminordistinctionbetween
the actions ofsome nonmutagenic chemicals, it has impor-
tant implications. For example, the adaptive process may
beintrinsicallymorereversiblethantheinductiveprocess.
In the absence of the chemical, reversion to a normal
phenotype may be possible. Numerous examples ofrever-
sion orremodelinghavebeen seen in studies ofhepatocar-
cinogenesis andintheneoplastictransformation ofcellsin
culture (21). However, mutation is a process and mutants
235236 R. W TENNANT
are aproductthatcanbestudiedand quantitatedfarmore
readily than can changes in the patterns of gene tran-
scription. It is necessary to explore further the complex
molecular interactions oftranscription factors with DNA
binding sites and to determine if specific chemicals can
dysregulate the expression of critical control genes in
ways that do not involve changes in DNA sequence (23).
Thus, I am proposing that at least some portion of
cancers are diseases of transcription that arise through
mistakes inthecomplexprocess oftranscriptional regula-
tion and that some chemicals have the capacity to illicit
such changes independent of their ability to stimulate
cellularproliferation. Induced cellularproliferation, there-
fore, maybeanessential componentallowingfortheclonal
amplification of transcriptionally altered cells. However,
chemicals that can induce cellular proliferation directly
through amitogeniceffect, orindirectlythroughelicitinga
compensatoryresponsetothetoxiceffects ofthechemical,
are not necessarily carcinogenic. Other properties ofthe
chemical, related to their ability to specifically interfere
with the transcriptional process, may be the important
property that distinguishes this class of nonmutagenic
carcinogen from both other nonmutagens and mutagens
that are carcinogens.
REFERENCES
1. IARC. Monographs on the Evaluation of Carcinogenic Risks to
Humans. Overall Evaluations of Carcinogenicity, Supplement 7.
International Agency for Research on Cancer, Lyon, 1987.
2. Cairns, J. The origin ofhuman cancers. Nature 289: 353-357 (1981).
3. Henderson, B. E., Ross, R. K., and Pike, M. C. Toward the primary
prevention ofcancer. Science 254: 1131-1137 (1991).
4. Boveri, T. The Origin of Malignant Thmors. Williams and Wilkins,
Baltimore, MD, 1929.
5. Solomon,E, Borrow, J., andGoddard, A. D. Chromosome aberrations
and cancer. Science 254: 1153-1160 (1991).
6. Bishop, M. Molecular themes in oncogenesis. Cell 64: 235-248 (1991).
7. Weinberg, R.A. Tumorsuppressorgenes. Science254: 1138-1145(1991).
8. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tu-
morigenesis. Cell 61: 759-767 (1990).
9. Ashby, J., and Tennant, R.W. Definitive relationships between chemi-
cal structure, carcinogenicity and mutagenicity for 301 chemicals
tested by the US NTP. Mutat. Res. 257: 229-306 (1991).
10. Haseman, J. K., Huff, J. E., Rao, G. N., Arnold, J. E., Boorman, G. A.,
and McConnell, E. E. Neoplasms observed in untreated and corn oil
gavage control groups ofF344/N rats and (C57B1/6N x C3H/Hen)
Fl (B6C3F1) mice. J. Natl. Cancer Inst. 75: 975-984 (1985).
11. Haseman, J. K., and Rao, G. N. Effects of corn oil, time-related
changes, and inter-laboratory variability on tumor occurrence in
control Fischer 344 (F344/N) rats. Toxicol. Pathol. 20: 52-60 (1992).
12. Drinkwater, N. R., and Ginsler, J. J. Genetic control of hepatocar-
cinogenesis in C57B1/6J and C3H/Hev inbred mice. Carcinogenesis
7: 1701-1707 (1986).
13. Eker, R., and Mossige, J. A. A dominant gene for renal adenomas in
the rat. Nature 189: 858-859 (1961).
14. Loeb, L. A. Endogenous carcinogenesis: molecular oncology into the
twenty-first century-presendial address. Cancer Res. 49: 5489-5496
(1989).
15. Totter, J. Spontaneous cancer and its possible relationship to oxygen
metabolism. Proc. Natl. Acad. Sci. USA 77: 1763-1767 (1980).
16. Cerutti, P., Larsson, R., and Krupitza, G. Mechanisms of Oxidadant
Carcinogenesis in Genetic Mechanisms in Carcinogens and Tumor
Progression. Wiley-Liss, Inc., 1990, pp. 69-82.
17. Ames, B. N., and Gold, L. S. Too many rodent carcinogens:
mitogenesis increases mutagenesis. Science 249: 970-971 (1990).
18. Reynolds, S. H., Stowers, S. J., Patterson, R. M., Maronpot, R. M.,
Aaronson, S. A., Anderson, M. W. Activated oncogenes in B6C3F1
mouse liver tumors: implications for risk assessment. Science 237:
1309-1316 (1987).
19. Tennant, R. W., Elwell, M. R., Spalding, J. W, and Griesemer, R. A.
Evidence that toxic injury is not always associated with induction of
chemical carcinogenesis. Mol. Carcinog. 4: 420-440 (1991).
20. Cohen, S. M., and Ellwein, L. B. Genetic errors, cell proliferation and
carcinogenesis. Cancer Res. 51: 6493-6505 (1991).
21. Farber, E., and Rubin, H. Cellular adaptation in the origin and
development ofcancer. Cancer Res. 51: 2751-2761 (1991).
22. Damm, K., Thompson, C. C., and Evans, R. M. Protein encoded by
v-erb A functions as a thyroid-hormone receptor antagonist. Nature
339: 593-597 (1989).
23. Issemann, I., and Green, S. Activation of a member of the steriod
hormone receptor superfamily by peroxisome proliferators. Nature
347: 645-650 (1990).